A type of treatment in which a patient's T cells (a type of immune system cell) are changed in the laboratory so they will attack cancer cells. T cells are taken from a patient?s blood. Then the gene for a special receptor that binds to a certain protein on the patient?s cancer cells is added to the T cells in the laboratory. The special receptor is called a chimeric antigen receptor (CAR). Large numbers of the CAR T cells are grown in the laboratory and given to the patient by infusion. CAR T-cell therapy is used to treat certain blood cancers, and it is being studied in the treatment of other types of cancer. Also called chimeric antigen receptor T-cell therapy.
This report aims to provide a comprehensive presentation of the global market for CAR-T Cellular Immunotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CAR-T Cellular Immunotherapy. This report contains market size and forecasts of CAR-T Cellular Immunotherapy in global, including the following market information:
Global CAR-T Cellular Immunotherapy Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global CAR-T Cellular Immunotherapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Allogeneic Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of CAR-T Cellular Immunotherapy include Fosun Kite Biotechnology, Gilead Sciences, Novartis and Bristol-Myers Squibb, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the CAR-T Cellular Immunotherapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global CAR-T Cellular Immunotherapy Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global CAR-T Cellular Immunotherapy Market Segment Percentages, by Type, 2022 (%)
Allogeneic
Autologous
Global CAR-T Cellular Immunotherapy Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global CAR-T Cellular Immunotherapy Market Segment Percentages, by Application, 2022 (%)
Hospital
Pharmacy
Other
Global CAR-T Cellular Immunotherapy Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global CAR-T Cellular Immunotherapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies CAR-T Cellular Immunotherapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies CAR-T Cellular Immunotherapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Fosun Kite Biotechnology
Gilead Sciences
Novartis
Bristol-Myers Squibb
Outline of Major Chapters:
Chapter 1: Introduces the definition of CAR-T Cellular Immunotherapy, market overview.
Chapter 2: Global CAR-T Cellular Immunotherapy market size in revenue.
Chapter 3: Detailed analysis of CAR-T Cellular Immunotherapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of CAR-T Cellular Immunotherapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 CAR-T Cellular Immunotherapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global CAR-T Cellular Immunotherapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global CAR-T Cellular Immunotherapy Overall Market Size
2.1 Global CAR-T Cellular Immunotherapy Market Size: 2022 VS 2030
2.2 Global CAR-T Cellular Immunotherapy Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top CAR-T Cellular Immunotherapy Players in Global Market
3.2 Top Global CAR-T Cellular Immunotherapy Companies Ranked by Revenue
3.3 Global CAR-T Cellular Immunotherapy Revenue by Companies
3.4 Top 3 and Top 5 CAR-T Cellular Immunotherapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies CAR-T Cellular Immunotherapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 CAR-T Cellular Immunotherapy Players in Global Market
3.6.1 List of Global Tier 1 CAR-T Cellular Immunotherapy Companies
3.6.2 List of Global Tier 2 and Tier 3 CAR-T Cellular Immunotherapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global CAR-T Cellular Immunotherapy Market Size Markets, 2022 & 2030
4.1.2 Allogeneic
4.1.3 Autologous
4.2 By Type - Global CAR-T Cellular Immunotherapy Revenue & Forecasts
4.2.1 By Type - Global CAR-T Cellular Immunotherapy Revenue, 2018-2023
4.2.2 By Type - Global CAR-T Cellular Immunotherapy Revenue, 2024-2030
4.2.3 By Type - Global CAR-T Cellular Immunotherapy Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global CAR-T Cellular Immunotherapy Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Pharmacy
5.1.4 Other
5.2 By Application - Global CAR-T Cellular Immunotherapy Revenue & Forecasts
5.2.1 By Application - Global CAR-T Cellular Immunotherapy Revenue, 2018-2023
5.2.2 By Application - Global CAR-T Cellular Immunotherapy Revenue, 2024-2030
5.2.3 By Application - Global CAR-T Cellular Immunotherapy Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global CAR-T Cellular Immunotherapy Market Size, 2022 & 2030
6.2 By Region - Global CAR-T Cellular Immunotherapy Revenue & Forecasts
6.2.1 By Region - Global CAR-T Cellular Immunotherapy Revenue, 2018-2023
6.2.2 By Region - Global CAR-T Cellular Immunotherapy Revenue, 2024-2030
6.2.3 By Region - Global CAR-T Cellular Immunotherapy Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America CAR-T Cellular Immunotherapy Revenue, 2018-2030
6.3.2 US CAR-T Cellular Immunotherapy Market Size, 2018-2030
6.3.3 Canada CAR-T Cellular Immunotherapy Market Size, 2018-2030
6.3.4 Mexico CAR-T Cellular Immunotherapy Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe CAR-T Cellular Immunotherapy Revenue, 2018-2030
6.4.2 Germany CAR-T Cellular Immunotherapy Market Size, 2018-2030
6.4.3 France CAR-T Cellular Immunotherapy Market Size, 2018-2030
6.4.4 U.K. CAR-T Cellular Immunotherapy Market Size, 2018-2030
6.4.5 Italy CAR-T Cellular Immunotherapy Market Size, 2018-2030
6.4.6 Russia CAR-T Cellular Immunotherapy Market Size, 2018-2030
6.4.7 Nordic Countries CAR-T Cellular Immunotherapy Market Size, 2018-2030
6.4.8 Benelux CAR-T Cellular Immunotherapy Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia CAR-T Cellular Immunotherapy Revenue, 2018-2030
6.5.2 China CAR-T Cellular Immunotherapy Market Size, 2018-2030
6.5.3 Japan CAR-T Cellular Immunotherapy Market Size, 2018-2030
6.5.4 South Korea CAR-T Cellular Immunotherapy Market Size, 2018-2030
6.5.5 Southeast Asia CAR-T Cellular Immunotherapy Market Size, 2018-2030
6.5.6 India CAR-T Cellular Immunotherapy Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America CAR-T Cellular Immunotherapy Revenue, 2018-2030
6.6.2 Brazil CAR-T Cellular Immunotherapy Market Size, 2018-2030
6.6.3 Argentina CAR-T Cellular Immunotherapy Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa CAR-T Cellular Immunotherapy Revenue, 2018-2030
6.7.2 Turkey CAR-T Cellular Immunotherapy Market Size, 2018-2030
6.7.3 Israel CAR-T Cellular Immunotherapy Market Size, 2018-2030
6.7.4 Saudi Arabia CAR-T Cellular Immunotherapy Market Size, 2018-2030
6.7.5 UAE CAR-T Cellular Immunotherapy Market Size, 2018-2030
7 CAR-T Cellular Immunotherapy Companies Profiles
7.1 Fosun Kite Biotechnology
7.1.1 Fosun Kite Biotechnology Company Summary
7.1.2 Fosun Kite Biotechnology Business Overview
7.1.3 Fosun Kite Biotechnology CAR-T Cellular Immunotherapy Major Product Offerings
7.1.4 Fosun Kite Biotechnology CAR-T Cellular Immunotherapy Revenue in Global Market (2018-2023)
7.1.5 Fosun Kite Biotechnology Key News & Latest Developments
7.2 Gilead Sciences
7.2.1 Gilead Sciences Company Summary
7.2.2 Gilead Sciences Business Overview
7.2.3 Gilead Sciences CAR-T Cellular Immunotherapy Major Product Offerings
7.2.4 Gilead Sciences CAR-T Cellular Immunotherapy Revenue in Global Market (2018-2023)
7.2.5 Gilead Sciences Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis CAR-T Cellular Immunotherapy Major Product Offerings
7.3.4 Novartis CAR-T Cellular Immunotherapy Revenue in Global Market (2018-2023)
7.3.5 Novartis Key News & Latest Developments
7.4 Bristol-Myers Squibb
7.4.1 Bristol-Myers Squibb Company Summary
7.4.2 Bristol-Myers Squibb Business Overview
7.4.3 Bristol-Myers Squibb CAR-T Cellular Immunotherapy Major Product Offerings
7.4.4 Bristol-Myers Squibb CAR-T Cellular Immunotherapy Revenue in Global Market (2018-2023)
7.4.5 Bristol-Myers Squibb Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. CAR-T Cellular Immunotherapy Market Opportunities & Trends in Global Market
Table 2. CAR-T Cellular Immunotherapy Market Drivers in Global Market
Table 3. CAR-T Cellular Immunotherapy Market Restraints in Global Market
Table 4. Key Players of CAR-T Cellular Immunotherapy in Global Market
Table 5. Top CAR-T Cellular Immunotherapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global CAR-T Cellular Immunotherapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global CAR-T Cellular Immunotherapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies CAR-T Cellular Immunotherapy Product Type
Table 9. List of Global Tier 1 CAR-T Cellular Immunotherapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 CAR-T Cellular Immunotherapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global CAR-T Cellular Immunotherapy Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - CAR-T Cellular Immunotherapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - CAR-T Cellular Immunotherapy Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global CAR-T Cellular Immunotherapy Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - CAR-T Cellular Immunotherapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - CAR-T Cellular Immunotherapy Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global CAR-T Cellular Immunotherapy Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global CAR-T Cellular Immunotherapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global CAR-T Cellular Immunotherapy Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America CAR-T Cellular Immunotherapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America CAR-T Cellular Immunotherapy Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe CAR-T Cellular Immunotherapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe CAR-T Cellular Immunotherapy Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia CAR-T Cellular Immunotherapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia CAR-T Cellular Immunotherapy Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America CAR-T Cellular Immunotherapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America CAR-T Cellular Immunotherapy Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa CAR-T Cellular Immunotherapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa CAR-T Cellular Immunotherapy Revenue, (US$, Mn), 2024-2030
Table 30. Fosun Kite Biotechnology Company Summary
Table 31. Fosun Kite Biotechnology CAR-T Cellular Immunotherapy Product Offerings
Table 32. Fosun Kite Biotechnology CAR-T Cellular Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 33. Fosun Kite Biotechnology Key News & Latest Developments
Table 34. Gilead Sciences Company Summary
Table 35. Gilead Sciences CAR-T Cellular Immunotherapy Product Offerings
Table 36. Gilead Sciences CAR-T Cellular Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 37. Gilead Sciences Key News & Latest Developments
Table 38. Novartis Company Summary
Table 39. Novartis CAR-T Cellular Immunotherapy Product Offerings
Table 40. Novartis CAR-T Cellular Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 41. Novartis Key News & Latest Developments
Table 42. Bristol-Myers Squibb Company Summary
Table 43. Bristol-Myers Squibb CAR-T Cellular Immunotherapy Product Offerings
Table 44. Bristol-Myers Squibb CAR-T Cellular Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 45. Bristol-Myers Squibb Key News & Latest Developments
List of Figures
Figure 1. CAR-T Cellular Immunotherapy Segment by Type in 2022
Figure 2. CAR-T Cellular Immunotherapy Segment by Application in 2022
Figure 3. Global CAR-T Cellular Immunotherapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global CAR-T Cellular Immunotherapy Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global CAR-T Cellular Immunotherapy Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by CAR-T Cellular Immunotherapy Revenue in 2022
Figure 8. By Type - Global CAR-T Cellular Immunotherapy Revenue Market Share, 2018-2030
Figure 9. By Application - Global CAR-T Cellular Immunotherapy Revenue Market Share, 2018-2030
Figure 10. By Type - Global CAR-T Cellular Immunotherapy Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global CAR-T Cellular Immunotherapy Revenue Market Share, 2018-2030
Figure 12. By Application - Global CAR-T Cellular Immunotherapy Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global CAR-T Cellular Immunotherapy Revenue Market Share, 2018-2030
Figure 14. By Region - Global CAR-T Cellular Immunotherapy Revenue Market Share, 2018-2030
Figure 15. By Country - North America CAR-T Cellular Immunotherapy Revenue Market Share, 2018-2030
Figure 16. US CAR-T Cellular Immunotherapy Revenue, (US$, Mn), 2018-2030
Figure 17. Canada CAR-T Cellular Immunotherapy Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico CAR-T Cellular Immunotherapy Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe CAR-T Cellular Immunotherapy Revenue Market Share, 2018-2030
Figure 20. Germany CAR-T Cellular Immunotherapy Revenue, (US$, Mn), 2018-2030
Figure 21. France CAR-T Cellular Immunotherapy Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. CAR-T Cellular Immunotherapy Revenue, (US$, Mn), 2018-2030
Figure 23. Italy CAR-T Cellular Immunotherapy Revenue, (US$, Mn), 2018-2030
Figure 24. Russia CAR-T Cellular Immunotherapy Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries CAR-T Cellular Immunotherapy Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux CAR-T Cellular Immunotherapy Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia CAR-T Cellular Immunotherapy Revenue Market Share, 2018-2030
Figure 28. China CAR-T Cellular Immunotherapy Revenue, (US$, Mn), 2018-2030
Figure 29. Japan CAR-T Cellular Immunotherapy Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea CAR-T Cellular Immunotherapy Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia CAR-T Cellular Immunotherapy Revenue, (US$, Mn), 2018-2030
Figure 32. India CAR-T Cellular Immunotherapy Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America CAR-T Cellular Immunotherapy Revenue Market Share, 2018-2030
Figure 34. Brazil CAR-T Cellular Immunotherapy Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina CAR-T Cellular Immunotherapy Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa CAR-T Cellular Immunotherapy Revenue Market Share, 2018-2030
Figure 37. Turkey CAR-T Cellular Immunotherapy Revenue, (US$, Mn), 2018-2030
Figure 38. Israel CAR-T Cellular Immunotherapy Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia CAR-T Cellular Immunotherapy Revenue, (US$, Mn), 2018-2030
Figure 40. UAE CAR-T Cellular Immunotherapy Revenue, (US$, Mn), 2018-2030
Figure 41. Fosun Kite Biotechnology CAR-T Cellular Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Gilead Sciences CAR-T Cellular Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Novartis CAR-T Cellular Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Bristol-Myers Squibb CAR-T Cellular Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
